Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02466802
Title Study of Regorafenib and Sildenafil for Advanced Solid Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Virginia Commonwealth University
Indications

Advanced Solid Tumor

Therapies

Regorafenib

Sildenafil

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.